In this issue:
Encorafenib, binimetinib and pembrolizumab for BRAF V600-mutant melanoma
Immune-checkpoint inhibition for melanoma brain metastases
5-year outcomes with cobimetinib + vemurafenib in BRAF V600-mutant melanoma
Photoimmunotherapy in recurrent head and neck SCC
Watchful waiting and BCC behaviour
Cochrane review of interventions for BCC
Dermoscopic criteria for irritated seborrheic keratosis vs SCC
Tumour site prognostic for Merkel cell carcinoma disease-specific death
Mohs cryosection concordance between surgeon and dermatopathologist
Please login below to download this issue (PDF)